Wellington Management's Therapeutics Portfolio

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.